FDA
label_change
· 2015-05-21
FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
Summary
FDA approved a supplemental application for Savella (milnacipran hydrochloride) filed by Allergan, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SAVELLA (MILNACIPRAN HYDROCHLORIDE)